Doctor profile · Federal record
Dr. Jennifer Hammond, NP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Greenville, NC
- NPI 1184053639
- Accepts Medicare
- MIPS 91.9 / 100 · 2023
- 13 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3282 Charles Blvd
Greenville, NC 27858
(252) 413-0720 - Mailing address
-
2004 Charity Ln
Winterville, NC 285907972
Credentials & registration
- NPI registered
- November 2013 — 13 yrs on file
- Profile last updated
- November 9, 2020
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- North Carolina #5006583
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184053639. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
25,907
Distinct HCPCS
10
Medicare allowed
$553,125
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,350 | 15 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 6,160 | 23 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 2,040 | 19 | $22 | |
86235 |
Measurement of antibody for assessment of autoimmune disorder, any method | 931 | 116 | $17 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 566 | 212 | $104 | |
36415 |
Insertion of needle into vein for collection of blood sample | 481 | 202 | $7 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 461 | 204 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 356 | 178 | $10 | |
85651 |
Red blood cell sedimentation rate, to detect inflammation, non-automated | 356 | 175 | $4 | |
J7050 |
Infusion, normal saline solution, 250 cc | 299 | 47 | $1 |
In context: peer comparison
Among 36 peers in Greenville Family Nurse Practitioner, average services per provider: 133. This provider delivers 195× the peer median.Open Payments
Industry payments received
All-time total
$1,044
Transactions
29
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 2 | $196.19 | |
| Ucb, INC. | 3 | $181.48 | |
| GlaxoSmithKline, LLC. | 5 | $115.58 | |
| Amgen INC. | 4 | $102.42 | |
| Janssen Biotech, INC. | 5 | $94.48 | |
| Janssen Pharmaceuticals, INC | 1 | $91.90 | |
| Boston Scientific Corporation | 2 | $72.03 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $62.30 | |
| Sanofi-Aventis U.S. LLC | 1 | $59.99 | |
| Pfizer INC. | 3 | $51.63 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $16.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,385
Patients
348
Total drug cost
$298,514
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 344 | 92 | $14,765 |
| Hydroxychloroquine Sulfate | Generic | 308 | 81 | $19,796 |
| Prednisone | Generic | 281 | 93 | $2,559 |
| Folic Acid | Generic | 87 | 22 | $338 |
| Gabapentin | Generic | 72 | 22 | $1,107 |
| Leflunomide | Generic | 57 | 20 | $3,424 |
| Allopurinol | Generic | 52 | 18 | $876 |
| Tramadol Hcl | Generic | 52 | 0 | $301 |
| Cyclobenzaprine Hcl | Generic | 26 | 0 | $136 |
| Humira(Cf) Pen (Adalimumab) | Brand | 21 | 0 | $152,199 |
Frequently asked questions
What is Dr. Jennifer Hammond's medical specialty?
Dr. Jennifer Hammond practices Family Nurse Practitioner in Greenville, NC.
Where does Dr. Jennifer Hammond practice?
Dr. Jennifer Hammond practices at 3282 Charles Blvd, Greenville, NC 27858. Office phone: 2524130720.
What is Dr. Jennifer Hammond's NPI?
Dr. Jennifer Hammond's National Provider Identifier (NPI) is 1184053639, issued by NPPES.
Does Dr. Jennifer Hammond accept Medicare assignment?
Yes. Dr. Jennifer Hammond accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jennifer Hammond commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.